PCN34 COST-EFFECTIVENESS OF ANASTROZOLE OVERTAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER FROM A UK NATIONAL HEALTH SERVICE PERSPECTIVE- THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67272-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)67272-5/fulltext
Title :
PCN34 COST-EFFECTIVENESS OF ANASTROZOLE OVERTAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER FROM A UK NATIONAL HEALTH SERVICE PERSPECTIVE- THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67272-5&doi=10.1016/S1098-3015(10)67272-5
First page :
Section Title :
Open access? :
No
Section Order :
502